Chilmark Research March 16, 2021
Delivering on the promise of digitized health records
In this Hot Take, we’re going to look at the implications and possibilities of an emerging market for clinical health care data. While healthcare data being for sale is nothing new, the idea of this type of detailed, computable patient data being available for purchase for the first time has ignited debate in the industry. As with most hot button topics in this industry, the situation is nuanced and deserves a closer look.
Life sciences companies and CROs are the stakeholders most interested in this data, which can be used to advance drug development for rare diseases, among other things. In a recent move that turned heads, instead of licensing data...